| 摘要 |
The invention relates to pharmaceutical compositions for improving the availability of active substances in mammals. The invention especially relates to compositions that make it possible to support the effect of isoflavones or iron on mammals. A particularly preferred composition is the combination of the genistein isoflavone and the Glu-Glu dipeptide. The invention further relates to the use of said compositions for treating and preventing cardiovascular diseases, diseases linked to increased platelet aggregation, metabolic diseases, bone diseases, or cancer diseases. The invention also relates to methods for producing medicaments, particularly for inhibiting platelet aggregation. According to said methods, isoflavones and negatively charged peptides are provided and mixed. |
